Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy.

Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med (1993) 5.00

Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology (2007) 3.78

Predictors of nonadherence to screening colonoscopy. J Gen Intern Med (2005) 2.80

Surveillance guidelines after removal of colorectal adenomatous polyps. Gut (2002) 2.71

Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol (2012) 1.98

Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health (2007) 1.86

Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia. Gastroenterology (2010) 1.74

Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Gastroenterology (2014) 1.69

Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial. Gut (2001) 1.63

Patients' experiences and reported barriers to colonoscopy in the screening context--a systematic review of the literature. Patient Educ Couns (2011) 1.60

Factors affecting abdominal pain during colonoscopy. Eur J Gastroenterol Hepatol (2007) 1.52

Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health (2006) 1.48

Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. The Polyp Prevention Study Group. Gastroenterology (1998) 1.40

Fecal occult blood testing when colonoscopy capacity is limited. J Natl Cancer Inst (2011) 1.33

Patient pain during colonoscopy: an analysis using real-time magnetic endoscope imaging. Endoscopy (2002) 1.31

What determines individuals' preferences for colorectal cancer screening programmes? A discrete choice experiment. Eur J Cancer (2010) 1.17

Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice. Cancer (2011) 1.13

Preferences for colorectal cancer screening strategies: a discrete choice experiment. Br J Cancer (2010) 1.10

Gender differences in predictors of colorectal cancer screening uptake: a national cross sectional study based on the health belief model. BMC Public Health (2013) 1.07

Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening. Cancer Epidemiol (2015) 1.03

Burden of colonoscopy compared to non-cathartic CT-colonography in a colorectal cancer screening programme: randomised controlled trial. Gut (2011) 0.96

Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity. United European Gastroenterol J (2013) 0.95

Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study. BMC Gastroenterol (2012) 0.91

Reasons for participation and nonparticipation in colorectal cancer screening: a randomized trial of colonoscopy and CT colonography. Am J Gastroenterol (2012) 0.86

Comparison of uptake of colorectal cancer screening based on fecal immunochemical testing (FIT) in males and females: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2014) 0.84

Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process. BMC Health Serv Res (2015) 0.84

Non- or full-laxative CT colonography vs. endoscopic tests for colorectal cancer screening: a randomised survey comparing public perceptions and intentions to undergo testing. Eur Radiol (2014) 0.78

Patient attitudes towards faecal immunochemical testing for haemoglobin as an alternative to colonoscopic surveillance of groups at increased risk of colorectal cancer. J Med Screen (2013) 0.78

What are the most important factors regarding acceptance to the colonoscopy?: study of related tolerance parameters. Arq Gastroenterol (2013) 0.77

Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials. Lancet (2015) 1.73

Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial. BMC Public Health (2016) 0.82